Chronotherapy With Low-dose Aspirin for Primary Prevention "CARING"

Recruiting

Phase 4 Results N/A

Summary of Purpose

Brief summary: Aspirin (ASA) has been shown to provide marked benefits in primary and secondary prevention of cardiovascular events. Substantial evidence suggests that low-dose ASA therapy should also be used as a primary prevention strategy in men and women with diabetes who are at high cardiovascular risk. On the other hand, there is current evidence on the potential benefits of low-dose ASA therapy in...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 30 November 2015.

1 Oct 2008 28 Jul 2008 1 Dec 2018 1 Jun 2019 1 Nov 2015 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Conditions

Sponsors

Trial Design

  • Allocation: Randomized
  • Masking: Open Label
  • Purpose: Prevention
  • Endpoint: Safety/Efficacy Study
  • Intervention: Parallel Assignment

Contacts